# Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept

> **NCT05203263** · NA · COMPLETED · sponsor: **Cryonove Pharma** · enrollment: 23 (actual)

## Conditions studied

- Solar Lentigo

## Interventions

- **DEVICE:** (810A-v1) device prototype
- **DEVICE:** (810B-v1) device prototype
- **DEVICE:** (810C-v1) device prototype

## Key facts

- **NCT ID:** NCT05203263
- **Lead sponsor:** Cryonove Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-15
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-02-15
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05203263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05203263, "Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05203263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*